Breast cancer medications linked to increased osteoporosis risk.
D047072:Aromatase Inhibitors / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000517:prevention & control; D017698:Postmenopause; D017741:Survivors
D047072:Aromatase Inhibitors